Real-world treatment patterns and clinical outcomes in Korean patients with AML ineligible for first-line intensive chemotherapy: A subanalysis of the CURRENT study, a non-interventional, retrospective chart review

Data Availability

All relevant data are within the manuscript. The data presented in this study are available from AbbVie Inc., North Chicago, IL, USA (contact via cynthia.llamas{at}abbvie.com or yinghui.duan{at}abbvie.com). Authors share the “minimal data set” for their submission. The minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods. Additionally, authors comply with field-specific standards for preparation, recording, and deposition of data when applicable.